Blood pressure control with active ultrafiltration measures and without antihypertensives is essential for survival in hemodiafiltration and hemodialysis programs for patients with CKD. A prospective observational study.

The main finding confirms the hypothesis of the study that there is more remarkable survival in the group of patients with CKD whose hypertension can be controlled without antihypertensive treatment and with the use of constant dry weight reduction measures to optimize ultrafiltration. The factors associated with the lack of control of arterial hypertension were a history of vascular amputation, a history of being an ex-smoker, being a carrier of type 2 diabetes mellitus, having a serum ferritin level greater than 26.75%, being male, and being treated with hemodialysis. The associated protective factors were having a diagnosis of glomerulonephritis as an etiology of chronic kidney disease, a history of never smoking, a serum ALB concentration greater than 4.214 g/dl, effective blood flow greater than 423.5 ml/min, and interdialytic weight gain >4.925%, hemodiafiltration as treatment, urea levels less than 103.78 mg/dl, and fasting glucose levels less than 109.2 mg/dl. According to the time-adjusted model, only four factors were associated: age, transferrin saturation, serum albumin levels, and history of vascular amputation.
In the stratified analysis, differences in survival were demonstrated by the percentiles of blood pressure taken in the last month of survival or censoring. With blood pressures ranging from 141 mmHg to 122 mmHg, there is a proportional risk of death associated with the intake of antihypertensive agents. The same occurs when the blood pressure is less than 105 mmHg. These relationships could not be established with pressures greater than 141 mmHg.
Follow the Topic
-
BMC Nephrology
This is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of kidney and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Related Collections
With collections, you can get published faster and increase your visibility.
Immune system regulation in the kidneys
BMC Nephrology invites submissions to our Collection on Immune system regulation in the kidneys.
Immune system regulation can play an important role in kidney function, with intricate mechanisms governing the interaction between the renal system and immune cells. Understanding the modulation and regulation of the immune system within the kidneys is essential for comprehending the pathophysiology of renal inflammation and immune-mediated kidney diseases. Research in this area encompasses the study of immune cell populations, immunosuppressive functions, and the maintenance of immune homeostasis within the renal microenvironment.
Advancing our collective understanding of immune system regulation in the kidneys is vital for identifying the underlying mechanisms of renal inflammation and immune-mediated kidney diseases. Recent advances have revealed the pivotal role of regulatory immune cells in maintaining immune homeostasis and preventing excessive immune activation within the kidneys. Furthermore, studies have highlighted the complex interplay between immune cells and renal cells, shedding light on the mechanisms of immune-mediated kidney injury and potential targets for therapeutic intervention.
Looking ahead, continued research in this area holds the potential for uncovering novel immunomodulatory pathways and therapeutic targets for immune-mediated kidney diseases. Future advances may include the development of targeted immunotherapies aimed at restoring immune homeostasis within the inflamed kidney microenvironment, as well as the identification of biomarkers for early detection and monitoring of immune-mediated kidney diseases.
Topics of interest include, but are not limited to:
Immune cell populations in the kidneys
Immunomodulatory mechanisms in renal inflammation
Regulatory T cells and immune homeostasis in the kidneys
Immune-mediated kidney diseases
Role of dendritic cells in renal immune regulation
The impact of gut microbiota on renal immune responses
Novel immunotherapies for immune-mediated kidney diseases
Crosstalk between innate and adaptive immune cells in renal inflammation
The influence of aging on immune regulation in the kidneys
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Mar 17, 2025
Omics approaches in nephrology: From gene to protein
BMC Nephrology invites submissions to our Collection, Omics approaches in nephrology: from gene to protein.
Advances in omics technologies have revolutionized the field of nephrology, allowing for a comprehensive understanding of the genetic, epigenetic and proteomic aspects of various kidney-related disorders. This Collection gathers research that uses omics approaches, including genomics, transcriptomics, proteomics, and metabolomics, to elucidate the molecular mechanisms underlying heritable kidney diseases, biomarker discovery, and genetic or genomic testing in the context of renal disorders.
It is crucial to continue advancing our collective understanding of the kidney genome, gene expression, and biochemical composition to unravel the complex architecture of the kidney and identify novel biomarkers for early diagnosis and personalized treatment of pathologies. Recent advances and new technologies in omics have led to the identification of novel genetic variants associated with nephropathology, glomerular diseases, electrolyte disturbances, tubulointerstitial disorders, and congenital anomalies of kidneys and urinary tract (CAKUT). Additionally, omics-based studies have provided insights into the molecular pathways involved in kidney stone formation, nephrocalcinosis, and acute/chronic rejection of renal allograft.
Topics of interest include, but are not limited to:
Genetic or genomic testing and heritable causes of kidney diseases
Biomarker discovery in kidney disorders
Omics-based insights into kidney diseases
Molecular mechanisms of glomerular and tubulointersitial kidney diseases
Epigenetic regulation in kidney diseases
Transcriptomic profiling (single cell/nucleus, spatial, etc.) in nephrology and nephrogenetics
Integrative omics analysis for personalized treatment in nephrology
Mechanisms and biomarkers of renal allograft diseases, including acute and chronic rejection, recurrence of kidney disease after transplantation, and viral nephritis
Unique pathological changes and molecular patterns in renal allograft rejection
Mechanisms and signs of native kidney disease recurrence after transplantation
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer-review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Feb 28, 2025
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in